Equity grant lifts Health Catalyst (HCAT) director to 185K shares
Health Catalyst director Julie Larson-Green received 9,766 restricted stock units (RSUs) under the company’s 2019 Stock Option and Incentive Plan. The RSUs vested immediately, increasing her holdings to 185,101 shares. The award was granted at no cash price, and no Rule 10b5-1 trading plan was reported.
How this was made
The 30-second read
Why it matters
The grant adds to insider ownership but is unlikely to move the stock given its small size and zero cash cost.
Market read
Low relevance; the filing is a routine insider compensation update with minimal trading implications.
What to watch
Potential future equity compensation plans or changes to the director's role could alter the significance of this grant.
Background
Form 4 filings disclose insider transactions; a fully vested RSU award to a non‑employee director is routine corporate governance disclosure.
Ticker impact
Health Catalyst disclosed a Form 4 showing director Julie Larson‑Green received 9,766 RSUs that fully vested on Sep 1 2026, raising her holdings to 185,101 shares.
No material move expected; the small size relative to float limits any short‑term effect.
Form 4 filings are primary sources; the transaction size is modest and fully vested at $0 cost, offering no new information for valuation.
Market effects
None; the grant does not affect the broader healthcare‑analytics sector.
None; limited to Health Catalyst shareholders.
None; the event is company‑specific and low‑impact.
Counterpoint
If the director plans to sell shares soon, the grant could signal upcoming supply pressure.
Key entities
- CompanyHealth Catalyst, Inc.
NASDAQ‑listed provider of data and analytics platforms for healthcare.
- DirectorJulie Larson‑Green
Non‑employee director of Health Catalyst receiving the RSU award.
